Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 17

    1.

    Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee.

    Sacks FM, Lichtenstein A, Van Horn L, Harris W, Kris-Etherton P, Winston M; American Heart Association Nutrition Committee.

    Circulation. 2006 Feb 21;113(7):1034-44. Epub 2006 Jan 17.PMID: 16418439 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Safety assessment of raloxifene over eight years in a clinical trial setting.

    Martino S, Disch D, Dowsett SA, Keech CA, Mershon JL.

    Curr Med Res Opin. 2005 Sep;21(9):1441-52.PMID: 16197663 [PubMed - indexed for MEDLINE]Related articles

    3.

    S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora.

    Setchell KD, Clerici C, Lephart ED, Cole SJ, Heenan C, Castellani D, Wolfe BE, Nechemias-Zimmer L, Brown NM, Lund TD, Handa RJ, Heubi JE.

    Am J Clin Nutr. 2005 May;81(5):1072-9.PMID: 15883431 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Selecting the appropriate rodent diet for endocrine disruptor research and testing studies.

    Thigpen JE, Setchell KD, Saunders HE, Haseman JK, Grant MG, Forsythe DB.

    ILAR J. 2004;45(4):401-16. Review.PMID: 15454679 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Lessons learned from perinatal exposure to diethylstilbestrol.

    Newbold RR.

    Toxicol Appl Pharmacol. 2004 Sep 1;199(2):142-50. Review.PMID: 15313586 [PubMed - indexed for MEDLINE]Related articles

    6.

    The role of selective estrogen receptor modulators in the prevention of breast cancer: comparison of the clinical trials.

    Martino S, Costantino J, McNabb M, Mershon J, Bryant K, Powles T, Secrest RJ.

    Oncologist. 2004;9(2):116-25. Review.PMID: 15047916 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones.

    Setchell KD, Brown NM, Lydeking-Olsen E.

    J Nutr. 2002 Dec;132(12):3577-84. Review.PMID: 12468591 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    From malformations to molecular mechanisms in the male: three decades of research on endocrine disrupters.

    McLachlan JA, Newbold RR, Burow ME, Li SF.

    APMIS. 2001 Apr;109(4):263-72. Review.PMID: 11469497 [PubMed - indexed for MEDLINE]Related articles

    9.

    Animal models impacted by phytoestrogens in commercial chow: implications for pathways influenced by hormones.

    Brown NM, Setchell KD.

    Lab Invest. 2001 May;81(5):735-47.PMID: 11351045 [PubMed - indexed for MEDLINE]Related articles

    10.

    Ability of xeno- and phytoestrogens to modulate expression of estrogen-sensitive genes in rat uterus: estrogenicity profiles and uterotropic activity.

    Diel P, Schulz T, Smolnikar K, Strunck E, Vollmer G, Michna H.

    J Steroid Biochem Mol Biol. 2000 May;73(1-2):1-10.PMID: 10822019 [PubMed - indexed for MEDLINE]Related articles

    11.

    Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist.

    Pike AC, Brzozowski AM, Hubbard RE, Bonn T, Thorsell AG, Engström O, Ljunggren J, Gustafsson JA, Carlquist M.

    EMBO J. 1999 Sep 1;18(17):4608-18.PMID: 10469641 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation.

    Cummings SR, Eckert S, Krueger KA, Grady D, Powles TJ, Cauley JA, Norton L, Nickelsen T, Bjarnason NH, Morrow M, Lippman ME, Black D, Glusman JE, Costa A, Jordan VC.

    JAMA. 1999 Jun 16;281(23):2189-97. Erratum in: JAMA 1999 Dec 8;282(22):2124. PMID: 10376571 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Effects of neonatal diethylstilbestrol (DES) exposure on morphology and growth patterns of endometrial epithelial cells in CD-1 mice.

    Yoshida A, Newbold RR, Dixon D.

    Toxicol Pathol. 1999 May-Jun;27(3):325-33.PMID: 10356709 [PubMed - indexed for MEDLINE]Related articles

    14.

    Isoflavone content of infant formulas and the metabolic fate of these phytoestrogens in early life.

    Setchell KD, Zimmer-Nechemias L, Cai J, Heubi JE.

    Am J Clin Nutr. 1998 Dec;68(6 Suppl):1453S-1461S. Review.PMID: 9848516 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta.

    Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA.

    Endocrinology. 1998 Oct;139(10):4252-63.PMID: 9751507 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Exposure of infants to phyto-oestrogens from soy-based infant formula.

    Setchell KD, Zimmer-Nechemias L, Cai J, Heubi JE.

    Lancet. 1997 Jul 5;350(9070):23-7.PMID: 9217716 [PubMed - indexed for MEDLINE]Related articles

    17.

    Long-term effects on the female mouse genital tract associated with prenatal exposure to diethylstilbestrol.

    McLachlan JA, Newbold RR, Bullock BC.

    Cancer Res. 1980 Nov;40(11):3988-99. No abstract available. PMID: 7193511 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data